Turkish Journal of Medical Sciences
Volume 47

Number 3

Article 30

1-1-2017

Comparative analysis of selected cagPAI genes and different
vacA genotypes in Iranian and Turkish H. pylori-positive patients
suffering from gastric adenocarcinoma and active chronic
gastritis
ALI BAHADORI
MOHAMMAD HOSSEIN SOMI
FİGEN DORAN
AMIR TAHER EFTEKHARSADAT
SUNA KIZILYILDIRIM

See next page for additional authors
Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
BAHADORI, ALI; SOMI, MOHAMMAD HOSSEIN; DORAN, FİGEN; EFTEKHARSADAT, AMIR TAHER;
KIZILYILDIRIM, SUNA; ESMAEILLOU, MAHSA; YASSI, MARYAM; BEDİR, BAŞAK; and KÖKSAL, FATİH (2017)
"Comparative analysis of selected cagPAI genes and different vacA genotypes in Iranian and Turkish H.
pylori-positive patients suffering from gastric adenocarcinoma and active chronic gastritis," Turkish
Journal of Medical Sciences: Vol. 47: No. 3, Article 30. https://doi.org/10.3906/sag-1606-116
Available at: https://journals.tubitak.gov.tr/medical/vol47/iss3/30

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Comparative analysis of selected cagPAI genes and different vacA genotypes in
Iranian and Turkish H. pylori-positive patients suffering from gastric
adenocarcinoma and active chronic gastritis
Authors
ALI BAHADORI, MOHAMMAD HOSSEIN SOMI, FİGEN DORAN, AMIR TAHER EFTEKHARSADAT, SUNA
KIZILYILDIRIM, MAHSA ESMAEILLOU, MARYAM YASSI, BAŞAK BEDİR, and FATİH KÖKSAL

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol47/iss3/30

Turkish Journal of Medical Sciences
http://journals.tubitak.gov.tr/medical/

Research Article

Turk J Med Sci
(2017) 47: 916-922
© TÜBİTAK
doi:10.3906/sag-1606-116

Comparative analysis of selected cagPAI genes and different vacA genotypes in Iranian
and Turkish H. pylori-positive patients suffering from gastric adenocarcinoma and active
chronic gastritis
1,

2

3

4

Ali BAHADORI *, Mohammad HOSSEIN SOMI , Figen DORAN , Amirtaher EFTEKHARSADAT ,
1
5
6
1
1
Suna KIZILYILDIRIM , Mahsa ESMAEILLOU , Maryam YASSI , Başak BEDİR , Fatih KÖKSAL
1
Department of Medical Microbiology, Faculty of Medicine, Çukurova University, Adana, Turkey
2
Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3
Department of Pathology, Faculty of Medicine, Çukurova University, Adana, Turkey
4
Imam Reza Hospital, Tabriz, Iran
5
Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran
6
Young Researchers and Elite Club, Mashhad Branch, Islamic Azad University, Mashhad, Iran
Received: 20.06.2016

Accepted/Published Online: 23.12.2016

Final Version: 12.06.2017

Background/aim: Helicobacter pylori is a pathogen that colonizes a majority of the world’s population. Genetic diversity within the
virulence genes of bacteria such as cagPAI and vacA may have a modified effect on the pathogenic potential of the bacteria. This study
aimed to investigate which genes can be suggested as potentially related virulence factors for H. pylori-associated active chronic gastritis
and stomach adenocarcinoma in the northwest of Iran and south of Turkey.
Materials and methods: Formalin-fixed, paraffin-embedded stomach biopsy tissue samples were obtained from Iranian and Turkish
patients from selected geographical regions. The prevalence of selected cagPAI genes and vacA genotypes were studied in H. pyloripositive samples by using polymerase chain reaction and specific primers.
Results: Out of 320 patients, H. pylori was detected in 28.43% of patients. We found that the vacAs1, vacAm2, and cagA genes with mean
prevalences of 82.41%, 71.42%, and 69.23%, respectively, were dominant in Iranian and Turkish patients.
Conclusion: In the south of Turkey and northwest of Iran the studied genes were homogeneous and there were no significant differences
in bacterial genetics. The results of this study indicate that cagA and vacAs1 are dominant genes in people with gastric disorders in our
selected geographical regions.
Key words: cagPAI, Helicobacter pylori, vacA, adenocarcinoma, chronic gastritis

1. Introduction
Today’s understanding of Helicobacter-related gastric
diseases in humans stems from an explosion in research
that occurred after the first culture of the organism by
Marshall and Warren in 1982 (1). Several risk factors for
gastric cancer have been identified but the clinical outcome
of Helicobacter pylori infection depends on host and
bacterial factors. Helicobacter is a genus of gram-negative
Epsilonproteobacteria usually found in the stomach. It is
a human pathogen responsible for chronic active gastritis;
infection by this organism is an important risk factor for
peptic ulcers, gastric cancer, and gastric mucosa-associated
lymphoid tissue lymphoma (2,3,4). As symptoms are often
absent or nonspecific in patients in the early stages of the
disease, gastric cancer is usually diagnosed at an advanced
* Correspondence: dr_ali_bahadori@yahoo.com
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stage, when curative options are limited. With exceptions
in countries that have developed screening programs
for early diagnoses, most patients with cancers reach
treatment already in advanced stages (5). The prevalence
of H. pylori infection varies between countries; generally,
the prevalence is about 30% in developed and more than
80% in developing countries (6). However, the incidence
of the cancer varies from region to region.
In recent years, many H. pylori virulence factors
have been characterized. The cytotoxin-associated gene
pathogenicity island (cagPAI) and vacuolating cytotoxin
gene A (vacA) are two identified virulence factors that are
considered to have an important role in the pathogenesis
of H. pylori infection (7). cagPAI is a nearly 40-kb cluster of
genes and is the most studied marker of H. pylori. There are
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31 open reading frames predicted within the cag region.
One of these open reading frames encodes the immune
dominant antigen CagA, which is localized to the -3′ end
of the island. CagA was identified as the first protein of
cagPAI and appeared to be a major virulence factor (8).
On the other hand, allelic variation can be seen in the vacA
genotypes. Allelic variation among Helicobacter pylori
vacA occurs in both the signal sequences (s region) and the
midregion (m region) of the gene. Strains with genotype
s1m1 produce high levels of vacuolating cytotoxin in vitro
(9,10). However, strains with genotype s2 produce an
inactive toxin (11).
2. Materials and methods
2.1. Sample collection
Our study was performed on 320 formalin-fixed, paraffinembedded (FFPE) tissues obtained from patients from the
northwest of Iran and south of Turkey. For the Turkish
population 80 paraffin blocks from patients with gastric
adenocarcinoma and 80 paraffin blocks from patients with
a nonadenocarcinoma diagnosis (chronic gastritis) were
obtained from the pathology archive of the Pathology
Department of the Medical Faculty of Çukurova University
(Balcalı Hospital) according to the histopathological
diagnosis reports. For the Iranian population the same
numbers of samples as mentioned above were taken from
the pathology archive of the Pathology Department of the
Medical Faculty of Tabriz University of Medical Sciences
(Imam Reza Hospital).
In order to determine the minimum amount of samples
to obtain sufficient DNA for analysis, we collected five to
seven 5-µm-thick cut sections from each selected paraffin
block by using a new disposable blade for each sample on
a semiautomatic microtome and placed them into 2.0mL polypropylene microcentrifuge tubes for H. pylori
DNA extraction. Deparaffinization (paraffin removal)
procedures as a preextraction treatment were used for FFPE
tissues according to guidelines by using xylene. To remove
the residual xylene, the samples were washed several times
with descending concentrations of ethanol. Finally, the
tubes were kept open for evaporation of remaining ethanol
(12). The DNA extraction procedure was performed with
the QIAamp DNA Kit (QIAGEN Inc., Germany) according
to the manufacturer’s instructions. Prepared DNAs were
stored at –20 °C. The total amount and purity of DNA for
each sample were assessed by spectrophotometry (CHE
BIOS, UV/Vis spectrophotometer). The total amount of
DNA was obtained in ng/µL, and the A260/280 ratio was
calculated for protein impurities. DNA was considered
viable for amplification when the A260/A280 ratio value
was from 1.7 to 2.0 (13).
2.2. PCR
PCR analyses were carried out to determine the presence
or absence of cagA, cagE, cagT, cagG, cagM, vacA s1, vacA

s2, vacA m1, and vacA m2 genes in each H. pylori-positive
sample. All PCR mixtures were performed in a total
volume of 25 µL. The glmM gene (urea C) was primarily
amplified for detection of H. pylori DNA in our samples
(14,15). In the rest of the study the amplification reactions
for each positive sample for the glmM gene were performed
by using specific primers and protocols (thermocycler: MJ
Mini, Bio-Rad) for the detection of the considered genes
(15–18). The sequences of primers used in this study and
sizes of amplicons are described in Table 1.
H. pylori 26695 DNA was used as a positive control
for cagPAI-positive strains (14). H. pylori-positive strains
for genes selected in this study were used as a control for
all the reactions performed (16). All stages of this study
were approved by the Ethics Committee of the Faculty of
Medicine, Çukurova University, Adana, Turkey.
2.3. Detection of PCR products
For analysis of the amplified products of each PCR assay,
6 µL of the amplicons were electrophoresed with a 1X
Tris-acetate-EDTA buffer on 2% agarose gel stained by
ethidium bromide (5 µL/100 mL). The amplicons were
visualized by UV transillumination and a 100-bp ladder
was used as standard.
3. Results
From the 320 patients, H. pylori (presence of glmM) was
detected in 91 patients (28.43%). Detailed demographic
data for the presence of different cagPAI genes and vacA
genotypes and histopathological findings are shown in
Table 2 and Figures 1 and 2.
Subsequently, combinations of genotypes were
made and then compared between the two groups
of patients, those with gastric adenocarcinoma and
nonadenocarcinoma diagnosis, in the Iranian and Turkish
patients of our study in order to understand the existence
of probable relationships between the presence of various
genes and the clinical and histopathological outcomes of
diseases. Associations between the presence of cagPAI
selected genes, vacA subtypes, and outcomes of disease are
shown in Table 2. Statistical differences in demographic
characteristics among the different disease groups were
determined by chi-square test (Table 2).
4. Discussion
Since the discovery of H. pylori, several studies have
focused on elucidating the microorganism’s pathogenicity
mechanisms associated with clinical outcome. Gastric
cancer is one of the most common worldwide cancers
and is a highly lethal disease. Establishment of H. pylori
as one of the risk factors for this kind of malignancy helps
to identify high-risk individuals; however, infection with
this organism is very common and most colonized people
never develop cancer. Thus, techniques to identify high-
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Table 1. Description of the pairs of primers used in the amplification of cagPAI and vacA genes.
Gene/primers

Sequence

Size/references

glmM

F: AAG CTT TTA GGG GTG TTA GGG GTT T
R: AAG CTT ACT TTC TAA CAC TAA CGC

294 bp (16,29,30)

cag A

F: GAT AAC AGG CAA GCT TTT GAG G
R: CTG CAA AAG ATT GTT TGG CAG A

349 bp (16,17,25)

cag E

F: TTGAAAACTTCAAGGATAGGATAGAGC
R: GCCTAGCGTAATATCACCATTACCC

508 bp (15,27,29)

cag T

F: CCATGTTTATACGCCTGTGT
R: CATCACCACACCCTT TTGAT

301 bp (16)

cag G

F: GCCATGTTAACACCCCCTAG
R: TTAATGCGCTAGAATAGTGC

497 bp (17)

cag M

F: ACAAATACAAAAAAGAAAAAGAGGC
R: ATTTTTCAACAAGTTAGAAAAAGCC

587 bp (17)

vacA s1

F: GTC AGC ATC ACA CCG CAA C
R: CTG CTT GAA TGC GCC AAA C

190 bp (30–32)

vacA s2

F: GCT AAC ACG CCA AAT GAT CC
R: CTG CTT GAA TGC GCC AAA C

199 bp (31)

vacA m1

F: GGTCAAAATGCGGTCATGG
R: CCATTGGTACCTGTAGAAAC

290 bp (13,31)

vacA m2

F: GGA GCC CCA GGA AAC ATT G
R: CAT AAC TAG CGC CTT GCA C

352 bp (13,32)

Table 2. Association between the presence of cagPAI selected genes, vacA subtypes, and disease outcome in Iranian and Turkish patients.
A.Ch.G

Cancer
P-value

Iran
(n = 17)

Turkey
(n = 19)

X

P-value

Total
(n=91)

3.813

0.050

10 (58.8)

15 (78.94)

1.712

0.1907

63 (69.23)

9 (32.1)

0.146

0.702

9 (52.94)

11 (57.89)

0.089

0.7652

39 (42.85)

7 (25.92)

8 (28.57)

0.049

0.8257

4 (23.52)

5 (26.31)

0.037

0.8472

24 (26.37)

cagG

3 (11.11)

3 (10.71)

0.002

0.9624

2 (11.76)

1 (5.26)

0.496

0.4811

9 (9.89)

cagM

1 (3.70)

1 (3.57)

0.001

0.9791

1 (5.88)

0

1.150

0.2836

3 (3.29)

vacAs1a

22 (81.48)

22 (78.57)

0.073

0.7874

14 (82.35)

17 (89.47)

0.047

0.8277

75 (82.41)

vacAs2

6 (22.22)

6 (21.42)

0.005

0.9432

0

0

--

---

12 (13.18)

vacAm1

7 (25.92)

7 (25)

0.006

0.9372

6 (35.29)

5 (26.31)

0.341

0.5593

25 (27.47)

vacAm2

21 (77.77)

22 (78.57)

0.005

0.9432

11 (64.70)

11 (57.89)

0.048

0.8259

65 (71.42)

vacAs1/m1

6 (22.22)

7 (25)

0.059

0.8085

6 (35.29)

7 (36.84)

0.009

0.9231

26 (28.57)

vacAs1/m2

14 (51.85)

15 (53.57)

0.016

0.8984

11 (64.70)

12 (63.15)

0.056

0.8134

53 (58.24)

VacAs2/m1

1 (3.70)

1 (3.57)

0.001

0.9791

0

0

--

--

2 (2.19)

vacAs2/m2

6 (22.22)

7 (25)

0.059

0.8085

0

0

--

--

13 (14.28)

Genotypes

Iran
(n = 27)

Turkey
(n = 28)

X

cagA

22 (81.48)

16 (57.14)

cagE

10 (37.0)

cagT
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Figure 1. The comparative distribution of selected H. pylori cagPAI genes and vacA genotypes in Turkish and
Iranian patients with active chronic gastritis.

Figure 2. The comparative distribution of selected H. pylori cagPAI genes and vacA genotypes in Turkish and
Iranian patients with gastric adenocarcinoma.

risk subpopulations must utilize other biological markers.
The prevalence of vacA genotypes and cagPAI component
genes in H. pylori isolates from different parts of the world
are various, and there is a direct association between
specific genotypes and certain clinical appearance. cagA,
as a marker for the presence of cagPAI, is one of the best
studied virulence factors for H. pylori. The frequency of
cagA-positive isolates has been reported to be nearly 25%–

60% in Bahrain, Israel, and Jordan and 60%–80% in some
other countries such as Taiwan, Turkey, Malaysia, and
India (19). According to one article, the cagA genotype
varied geographically from 44% to 94% in Iranian
populations (19). In the present study, we used simple PCR
for structural screening of selected cagPAI genes and vacA
genotypes in clinical isolates of H. pylori in FFPE gastric
biopsy specimens obtained from 320 patients suffering
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from active chronic gastritis and gastric adenocarcinoma.
The samples were obtained from two reference hospitals
in the northwest of Iran (Imam Reza Hospital) and
south of Turkey (Balcalı Hospital) (160 samples from
reference hospitals of each country, comprising 80 chronic
gastritis and 80 gastric adenocarcinoma samples), as two
neighboring developing countries where the prevalence
of H. pylori infection can be as high as 85%. H. pylori
was detected in 33.75% and 35% of Iranian and Turkish
patients with chronic gastritis and in 21.25% and 23.75% of
Iranian and Turkish patients with gastric adenocarcinoma,
respectively. The mean frequency of H. pylori infection
was 28.44% in all samples.
Based on previously published data, the prevalences
of cagA in Iranian isolates were 62%, 92%, and 68.7%
in Tehran, Jahrom, and Tabriz, respectively (20–23).
According to statistical analysis, in our study area in
Iran, there was no significant association between the
presence of selected cagPAI genes, vacA subtypes, and
gastric adenocarcinoma. However, the prevalence of some
selected genes was questionably high in patients suffering
from stomach adenocarcinoma and active chronic
gastritis. In a recent study by Ghotaslou et al. in 2013,
68.7% of the Iranian patients were infected with cagApositive strains. On the other hand, in a current study
from Turkey, Karaman et al. reported a cagA positivity
rate of 65.5% and they also found a significant relationship
between cagA status and peptic ulcer disease (22). Saltık et
al. reported the cagA positivity rate as 55.6% in 45 isolates
and they found no significant difference between cagA
positivity and the severity of gastroduodenal symptoms
(24). It is known that cagA positivity rates and their
association with clinical outcomes differ from region to
region. For example, studies from East and South Asian
countries show that more than 90% of the strains carry
the cagA gene regardless of clinical outcome. In general,
the cagA prevalence rate has been found to be between
around 50% to 70% in Middle Eastern countries, whereas
in East Asian countries almost all isolated strains are cagApositive. According to our data the cagA positivity rate in
Turkey for chronic gastritis and gastric adenocarcinoma
was 57.14% and 78.94%, respectively, and these rates in
Iranian patients were 81.48% and 58.8%.
The chaperone-like protein CagT plays an essential
role in the translocation of cagA into host cells (25) and
our results showed that the prevalence of cagT in Iranian
strains was lower than in Turkey. This may be one of
the reasons why cagA does not play a clear role in the
formation of gastric adenocarcinoma in Iran.
Like cagA, cagE belongs to the cagPAI and it is responsible
for binding to cell receptors and inducing the release of
IL-8 (26). In our samples cagE was found in 52.94% and
57.89% of Iranian and Turkish adenocarcinoma samples
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respectively and for chronic gastritis samples it was 37%
and 32.1% in Iranian and Turkish patient samples, which
reflects an important result, showing that this gene, like
cagA, or in cooperation with cagA, may be related to the
formation of active chronic gastritis and gastric cancer
development in both countries. This study demonstrates
that it is probable that infection with a cagE-positive H.
pylori strain is associated with gastric disorders such as
gastritis and adenocarcinoma in Iranian and Turkish
patients in the selected areas. We found that cagE, not only
cagA, could be used as a marker for the presence of cagPAI
in our selected geographical regions.
Although the prevalence of strains positive for cagE,
cagT, cagM, vacAs1, and vacAm2 in Iran and Turkey is
similar, we can suggest that vacAs1, vacAm2, and cagA
positivity be considered as essential virulence factors for
the development of most severe gastric diseases, like gastric
adenocarcinoma, in the Iranian and Turkish populations.
The results of the present study demonstrate that vacA
subtypes s1 and m2 are dominant in Iran and Turkey,
similar to other Middle East countries, and the frequencies
of s1m2 in patients with active chronic gastritis and s1m1
in patients with adenocarcinoma were relatively high.
The s2m2 genotypes were much lower compared to
other publications from Iran (27%) and also around the
world (0%–57%) (27).
Due to limitations in obtaining fresh endoscopy
samples from patients, we used paraffin-embedded
tissue blocks. Although formalin fixation with paraffin
embedding is the universal method for tissue preservation
and stabilization prior to histological evaluation by
pathologists (28), the effectiveness of PCR using DNA
gained from FFPE tissue is affected by multiple factors,
including the type of fixative used, the fixation time, the
DNA extraction method, the length of the PCR target, the
concentration of DNA, and the PCR protocol itself. Low
percentages of extracted DNA and false negative responses
are thus the main disadvantages of this method.
In conclusion, similar to studies performed in the
Middle East, the association between cagA and cagE
positivity and the virulence of H. pylori strains was
remarkable among patients from the northwest of Iranian
and south of Turkey with different disease outcomes.
According to information obtained from this investigation,
we can conclude that in patient groups selected from the
south of Turkey and northwest of Iran it seems that the
genes that were studied are homogeneous and in this era
there is no significant difference in bacterial genetics. The
results of this study indicate that cagA and vacAs1 are
dominant in our studied area. However, in this population
there is no statistically significant association between
these factors and gastric cancer. It is possible that if the
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statistical population increases, the association of cagA
with cancer might be meaningful. It can be concluded that
with the exception of H. pylori infection other factors such
as host genetics and nourishment play important roles in
the formation of gastric cancer in the populations of our
studied areas from Iran and Turkey. Considering the gap

of information observed during our research relating to
genotyping and other aspects of H. pylori infection, in
order to achieve our goals further advanced molecular
investigations like DNA sequencing analysis and studies of
larger statistical populations from different geographical
regions from Iran and Turkey are recommended.
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